Aug. 10, 2006 |
|
Dec. 17, 2018 |
|
jRCT2080220290 |
Add-on, open-label, phase III study of CS-866AZ |
|
version: date: |
DAIICHI SANKYO COMPANY, LIMITED |
||
http://www.daiichisankyo.co.jp/contact/index.html |
||
Interventional |
||
Open |
||
3 |
||
Patient with essential hypertension not adequately controlled by CS-866 and CS-905 monotherapy, aged 20 years or older |
||
20age old over | ||
No limit | ||
Both |
||
Essential hypertension |
||
investigational material(s) |
||
Efficacy and safety |
||
DAIICHISANKYO Co.,Ltd. | |
JapicCTI-060295 | |